Novo Nordisk's semaglutide ... developed as a once-weekly injection that has already been shown to provide good control of blood glucose in phase III trials, with a low risk of low blood sugar ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...